NO20062916L - Overflatelokaliserte campylobacter jejuni-polypeptider - Google Patents
Overflatelokaliserte campylobacter jejuni-polypeptiderInfo
- Publication number
- NO20062916L NO20062916L NO20062916A NO20062916A NO20062916L NO 20062916 L NO20062916 L NO 20062916L NO 20062916 A NO20062916 A NO 20062916A NO 20062916 A NO20062916 A NO 20062916A NO 20062916 L NO20062916 L NO 20062916L
- Authority
- NO
- Norway
- Prior art keywords
- campylobacter
- polypeptides
- campylobacter jejuni
- localized
- surface localized
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 241000589875 Campylobacter jejuni Species 0.000 title abstract 2
- 241000589876 Campylobacter Species 0.000 abstract 2
- 238000002255 vaccination Methods 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200301726 | 2003-11-21 | ||
| US52461703P | 2003-11-25 | 2003-11-25 | |
| PCT/DK2004/000803 WO2005049641A2 (en) | 2003-11-21 | 2004-11-19 | Surface-located campylobacter jejuni polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20062916L true NO20062916L (no) | 2006-08-21 |
Family
ID=43426113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20062916A NO20062916L (no) | 2003-11-21 | 2006-06-21 | Overflatelokaliserte campylobacter jejuni-polypeptider |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20070178110A1 (de) |
| EP (1) | EP1694697B1 (de) |
| JP (1) | JP2008501625A (de) |
| KR (1) | KR20060129229A (de) |
| CN (1) | CN1906210A (de) |
| AT (1) | ATE493431T1 (de) |
| AU (1) | AU2004291213B2 (de) |
| CA (1) | CA2546873A1 (de) |
| DE (1) | DE602004030824D1 (de) |
| DK (1) | DK1694697T3 (de) |
| ES (1) | ES2358804T3 (de) |
| NO (1) | NO20062916L (de) |
| PL (1) | PL1694697T3 (de) |
| WO (1) | WO2005049641A2 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1765861B1 (de) * | 2004-06-18 | 2012-02-15 | Enkam Pharmaceuticals A/S | Fgfr-bindende peptide |
| EA013016B1 (ru) * | 2005-03-31 | 2010-02-26 | Лейден Юниверсити Медикал Сентер | Способы и средства диагностики, профилактики и лечения инфекций mycobacterium и заболевания туберкулезом |
| US9047864B2 (en) | 2009-07-16 | 2015-06-02 | Washington State University | Antigen compositions and methods of inhibiting Campylobacter jejuni bacterial infection and uses of the antigen compositions |
| CA2800830C (en) | 2010-06-09 | 2020-09-08 | The Board Of Trustees Of The University Of Arkansas | Vaccine and methods to reduce campylobacter infection |
| CN104159601B (zh) | 2012-02-01 | 2017-05-24 | 代表亚利桑那大学的亚利桑那董事会 | 弯曲杆菌属免疫原性组合物及其用途 |
| US10248758B2 (en) * | 2013-02-07 | 2019-04-02 | University Of Washington Through Its Center For Commercialization | Self-assembling protein nanostructures |
| US10376571B2 (en) | 2013-03-15 | 2019-08-13 | The Board Of Trustees Of The University Of Arkansas | Compositions and methods of enhancing immune responses to enteric pathogens |
| KR20190015712A (ko) | 2016-05-03 | 2019-02-14 | 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 | 면역자극 및 항원 폴리펩티드를 포함하는 효모 백신 벡터, 및 그를 이용하는 방법 |
| CN110520153B (zh) * | 2017-01-27 | 2024-04-02 | 佛罗里达大学研究基金公司 | 在禽类中控制肠道沙门氏菌和减少弯曲杆菌的食品安全疫苗 |
| US12297258B2 (en) * | 2018-07-17 | 2025-05-13 | Humabs Biomed Sa | Antibodies against Campylobacter species |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5200344A (en) * | 1990-11-13 | 1993-04-06 | Blaser Martin J | Diagnostic testing for campylobacter jejuni or campylobacter coli infections using novel antigens |
| CA2286306A1 (en) * | 1997-04-01 | 1998-10-08 | Human Genome Sciences, Inc. | Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome |
| AU3458299A (en) * | 1998-03-31 | 1999-10-18 | United States Of America, As Represented By The Secretary Of Agriculture, The | Monoclonal antibodies against (campylobacter jejuni) and (campylobacter coli) outer membrane antigens |
| US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
| JP2000351735A (ja) * | 1999-04-09 | 2000-12-19 | Akzo Nobel Nv | カンピロバクターワクチン |
| CA2296869A1 (en) * | 2000-01-24 | 2001-07-24 | Angela Joe | A surface-exposed lipoprotein to campylobacter jejuni involved in adherence to hep-2 cells |
| AU2002306849A1 (en) * | 2001-03-21 | 2002-10-08 | Elitra Pharmaceuticals, Inc. | Identification of essential genes in microorganisms |
-
2004
- 2004-11-19 ES ES04797464T patent/ES2358804T3/es not_active Expired - Lifetime
- 2004-11-19 AT AT04797464T patent/ATE493431T1/de not_active IP Right Cessation
- 2004-11-19 EP EP04797464A patent/EP1694697B1/de not_active Expired - Lifetime
- 2004-11-19 CA CA002546873A patent/CA2546873A1/en not_active Abandoned
- 2004-11-19 KR KR1020067012402A patent/KR20060129229A/ko not_active Ceased
- 2004-11-19 CN CNA2004800397129A patent/CN1906210A/zh active Pending
- 2004-11-19 US US10/595,909 patent/US20070178110A1/en not_active Abandoned
- 2004-11-19 DK DK04797464.7T patent/DK1694697T3/da active
- 2004-11-19 WO PCT/DK2004/000803 patent/WO2005049641A2/en not_active Ceased
- 2004-11-19 JP JP2006540171A patent/JP2008501625A/ja active Pending
- 2004-11-19 DE DE602004030824T patent/DE602004030824D1/de not_active Expired - Lifetime
- 2004-11-19 PL PL04797464T patent/PL1694697T3/pl unknown
- 2004-11-19 AU AU2004291213A patent/AU2004291213B2/en not_active Expired - Fee Related
-
2006
- 2006-06-21 NO NO20062916A patent/NO20062916L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HK1097854A1 (en) | 2007-07-06 |
| DK1694697T3 (da) | 2011-04-18 |
| PL1694697T3 (pl) | 2011-05-31 |
| EP1694697A2 (de) | 2006-08-30 |
| ES2358804T3 (es) | 2011-05-13 |
| AU2004291213A1 (en) | 2005-06-02 |
| US20070178110A1 (en) | 2007-08-02 |
| CN1906210A (zh) | 2007-01-31 |
| KR20060129229A (ko) | 2006-12-15 |
| AU2004291213B2 (en) | 2011-09-08 |
| EP1694697B1 (de) | 2010-12-29 |
| WO2005049641A2 (en) | 2005-06-02 |
| JP2008501625A (ja) | 2008-01-24 |
| ATE493431T1 (de) | 2011-01-15 |
| WO2005049641A3 (en) | 2005-10-20 |
| DE602004030824D1 (de) | 2011-02-10 |
| CA2546873A1 (en) | 2005-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004083816A3 (en) | Loss of heterozygosity of the dna markers in the 12q22-23 region | |
| NO20065084L (no) | Interferon-alfa polypeptider og konjugater | |
| BRPI0606790A2 (pt) | anticorpo humano isolado ou porção de ligação de antìgeno do mesmo, polipeptìdeo isolado, composição, ácido nucleico isolado, vetor de expressão célula hospedeira, vacina contra a raiva, kit, uso de um anticorpo monoclonal humano isolado ou porção de ligação de antìgeno do mesmo, ou de uma quantidade eficaz de uma composição, método para identificar um anticorpo ou um fragmento do mesmo, anticorpo ou fragmento do mesmo, anticorpo ou fragmento do mesmo,e, glicoproteìna. | |
| WO2002092836A3 (en) | Nucleic acid sequence encoding ovarian antigen, ca125, and uses thereof | |
| NO20006681D0 (no) | Fremgangsmåte ved tidlig diagnose av karsinomer | |
| WO2000029008A3 (en) | Hiv-specific t-cell induction | |
| NO20080590L (no) | Humane, monoklonale antistoffer mot programmert dodsligand (PD-L1) | |
| DK1576967T3 (da) | Rekombinant protein, der bærer epitoper fra det humane papillomvirus indsat i et adenylatcyclaseprotein eller et fragment deraf samt dets terapeutiske anvendelse | |
| WO2006063042A3 (en) | Selecting patients for therapy with a her inhibitor | |
| IL188460A0 (en) | Diagnostic methods and compositions for diagnosing and treating influenza | |
| WO2006103666A3 (en) | Isolated bid polypeptides, polynucleotides encoding same and antibodies directed thereagainst and methods of using same for inducing cell cycle arrest or apoptosis | |
| TR199800613A1 (xx) | Nezle A��s�. | |
| NO20082559L (no) | Humane monoklonale antistoffer mot protein tyrosin kinase 7 (PTK7) og fremgangsmater for anvendelse av anti-PTK7 antistoffer | |
| DK1005540T3 (da) | IKK-beta-proteiner, nukleinsyrer og fremgangsmåder | |
| EP1281755A3 (de) | Humane cyp2d6 Genvarianten | |
| NO20052363L (no) | Interferon-alfa polypeptider og konjugater | |
| WO2002074237A3 (en) | Compositions and methods for the therapy and diagnosis of kidney cancer | |
| CY1117746T1 (el) | Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna | |
| WO2003055917A3 (en) | Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours | |
| DK1694697T3 (da) | Overfladelokaliserede Campylobacter jejuni-polypeptider | |
| DE602006010544D1 (de) | Mit dem risiko von obesität und typ-2-diabetes assoziierter haplotyp des gens enpp1 (pc1) und anwendungen davon | |
| WO2006062402A3 (en) | Heat shock proteins (hsp) and supraventricular arrhythmia | |
| MXPA05011085A (es) | Composiciones y metodos relacionados a stop-1. | |
| NO20063375L (no) | Agonist-anti-trkC-antistoffer og fremgangsmater for a anvende disse | |
| DE60132443D1 (de) | In lebenden zielzellen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |